• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体替代途径的激活与“持续激活”的历程。

Initiation of the alternative pathway of complement and the history of "tickover".

作者信息

Pangburn Michael K

机构信息

Center for Biomedical Research, University of Texas Health Science Center, Tyler, Texas, USA.

出版信息

Immunol Rev. 2023 Jan;313(1):64-70. doi: 10.1111/imr.13130. Epub 2022 Sep 11.

DOI:10.1111/imr.13130
PMID:36089768
Abstract

The evolutionary history of complement suggests that the alternative pathway arose prior to the arrival of the classical and lectin pathways. In these pathways, target specificity is provided by antibodies and sugar specific lectins. While these efficient initiation systems dominate activation on most targets, the alternative pathway produces most of the C3b and 80%-90% of the C5b-9. While the tickover process, originally proposed by Peter Lachmann, provided ancient hosts with a crude self/non-self-discriminatory system that initiated complement attack on everything foreign, tickover clearly plays a more minor role in complement activation in modern organisms possessing classical and lectin pathways. Spontaneous activation of the alternative pathway via tickover may play a major role in human pathologies where tissue damage is complement-mediated. The molecular mechanism of tickover is still not convincingly proven. Prevailing hypotheses include (a) spontaneous hydrolysis of the thioester in C3 forming the C3b-like C3(H O) in solution and (b) "enhanced tickover" in which surfaces cause specific or non-specific contact activated conformational changes in C3. Theoretical considerations, including computer simulations, suggest that the latter mechanism is more likely and that more research needs to be devoted to understanding interactions between biological surfaces and C3.

摘要

补体的进化史表明,替代途径在经典途径和凝集素途径出现之前就已产生。在这些途径中,抗体和糖特异性凝集素提供靶标特异性。虽然这些高效的起始系统在大多数靶标上主导激活过程,但替代途径产生了大部分的C3b以及80%-90%的C5b-9。虽然最初由彼得·拉赫曼提出的持续激活过程为古老的宿主提供了一种粗糙的自我/非自我识别系统,可启动对所有外来物质的补体攻击,但在拥有经典途径和凝集素途径的现代生物体中,持续激活在补体激活中显然只起较小的作用。通过持续激活实现的替代途径的自发激活可能在组织损伤由补体介导的人类病理状况中起主要作用。持续激活的分子机制仍未得到令人信服的证实。流行的假说是:(a)C3中的硫酯自发水解,在溶液中形成类似C3b的C3(H₂O);(b)“增强持续激活”,即表面导致C3发生特异性或非特异性接触激活的构象变化。包括计算机模拟在内的理论思考表明,后一种机制更有可能,并且需要投入更多研究来理解生物表面与C3之间的相互作用。

相似文献

1
Initiation of the alternative pathway of complement and the history of "tickover".补体替代途径的激活与“持续激活”的历程。
Immunol Rev. 2023 Jan;313(1):64-70. doi: 10.1111/imr.13130. Epub 2022 Sep 11.
2
Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum.通过对全血清中能抑制点突变的 Ab(S77)的研究,证实了 C3 点突变假说。
FASEB J. 2018 Jan;32(1):123-129. doi: 10.1096/fj.201700734. Epub 2017 Aug 29.
3
Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3.由于C3硫酯的自发水解而启动替代补体途径。
Ann N Y Acad Sci. 1983;421:291-8. doi: 10.1111/j.1749-6632.1983.tb18116.x.
4
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.替代补体途径初始C3转化酶的形成。通过天然C3中假定硫酯的自发水解获得C3b样活性。
J Exp Med. 1981 Sep 1;154(3):856-67. doi: 10.1084/jem.154.3.856.
5
Physiology and pathology of the C3 amplification cycle: A retrospective.C3 扩增循环的生理学和病理学:回顾。
Immunol Rev. 2023 Jan;313(1):217-224. doi: 10.1111/imr.13165. Epub 2022 Nov 21.
6
Assessment of the Role of C3(HO) in the Alternative Pathway.评估 C3(HO) 在替代途径中的作用。
Front Immunol. 2020 Mar 31;11:530. doi: 10.3389/fimmu.2020.00530. eCollection 2020.
7
The tick-over theory revisited: is C3 a contact-activated protein?重温滴答理论:C3 是一种接触激活蛋白吗?
Immunobiology. 2012 Nov;217(11):1106-10. doi: 10.1016/j.imbio.2012.07.008.
8
Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.一种用于定量检测人血清中替代补体途径激活的酶联免疫吸附测定法的开发与应用。
J Clin Invest. 1984 Jan;73(1):160-70. doi: 10.1172/JCI111187.
9
Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.补体C3中假定硫酯键与替代途径激活及C3b与补体生物学靶点结合的关系。
J Exp Med. 1980 Oct 1;152(4):1102-14. doi: 10.1084/jem.152.4.1102.
10
Is generation of C3(HO) necessary for activation of the alternative pathway in real life?在现实生活中,C3(HO)的产生是否是替代途径激活所必需的?
Mol Immunol. 2019 Oct;114:353-361. doi: 10.1016/j.molimm.2019.07.032. Epub 2019 Aug 22.

引用本文的文献

1
Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder.腺苷酸琥珀酸裂解酶缺乏症中补体系统在诱导神经炎症方面的新作用。
Brain Behav Immun Health. 2025 Aug 19;48:101091. doi: 10.1016/j.bbih.2025.101091. eCollection 2025 Oct.
2
Complement Cascades and Brain Disorders.补体级联反应与脑部疾病
Biomolecules. 2025 Aug 17;15(8):1179. doi: 10.3390/biom15081179.
3
Impact of smoking on the complement system: a narrative review.吸烟对补体系统的影响:一项叙述性综述。
Front Immunol. 2025 Jun 19;16:1619835. doi: 10.3389/fimmu.2025.1619835. eCollection 2025.
4
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of HSK39297 in Chinese Healthy Subjects: A Phase 1 Clinical Trial.HSK39297在中国健康受试者中的药代动力学、药效学、安全性及耐受性:一项1期临床试验
Clin Transl Sci. 2025 Jul;18(7):e70281. doi: 10.1111/cts.70281.
5
A percolation phase transition controls complement protein coating of surfaces.渗流相变控制表面的补体蛋白包被。
Cell. 2025 Jun 12. doi: 10.1016/j.cell.2025.05.026.
6
Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration.苔藓衍生的人补体因子H调节视网膜免疫反应并减轻视网膜变性。
J Neuroinflammation. 2025 Apr 11;22(1):104. doi: 10.1186/s12974-025-03418-2.
7
The specific contributions of factor H and factor I in controlling fluid phase activation of the alternative complement pathway.补体替代途径中H因子和I因子在控制液相激活方面的具体作用。
Sci Rep. 2025 Mar 29;15(1):10883. doi: 10.1038/s41598-025-95533-6.
8
The curious case of AAV immunology.腺相关病毒免疫学的奇特案例。
Mol Ther. 2025 May 7;33(5):1946-1965. doi: 10.1016/j.ymthe.2025.03.037. Epub 2025 Mar 27.
9
Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy.IgA肾病发病机制中的新兴生化和免疫机制
Semin Nephrol. 2024 Sep;44(5):151565. doi: 10.1016/j.semnephrol.2025.151565. Epub 2025 Mar 13.
10
Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46.非典型溶血尿毒综合征:通过对补体调节蛋白CD46的分析对发病机制的遗传学见解
Ann Blood. 2023 Sep 30;8. doi: 10.21037/aob-22-40. Epub 2023 Apr 11.